Carregant...
‘Optimism bias’ in contemporary national clinical trial network phase III trials: are we improving?
BACKGROUND: Previous studies have found that overestimating treatment effects (i.e. ‘optimism bias’) leads to underpowered clinical trials. The prevalence of ‘optimism bias’ in contemporary National Clinical Trials Network (NCTN) cancer clinical trials is unknown. METHODS: We conducted a systematic...
Guardat en:
| Publicat a: | Ann Oncol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6454418/ https://ncbi.nlm.nih.gov/pubmed/30412223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdy340 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|